Armata Pharmaceuticals Inc. – Filings and Transcripts

NYSE American: ARMP
Share price (5/28/26): $8.12
Market cap (5/28/26): $298 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Gilmer Daniel B.

Gilmer Daniel B.

News Filter

Announces First Quarter 2026 Results and Provides Corporate Update

Secures FDA Fast Track Designation for AP-SA02

Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. to Its Board of Directors

Announces Fourth Quarter and Full-Year 2025 Financial Results

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission